Physician profile
Alice Wuu
NPI 1245557347
$9,187.54
in general payments reported to CMS, 2019-2025
41 companies · $1,537 in 2025
The $1,537 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,691 · 2020: $969 · 2021: $890 · 2022: $1,368 · 2023: $1,311 · 2024: $1,422 · 2025: $1,537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,099 · Education: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,098.68 |
| Education | $171.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,060.74 | 2019-2025 | Rinvoq, Skyrizi |
| Galderma Laboratories, L.P. | $1,161.27 | 2019-2025 | Nemluvio, Aklief, Twyneo |
| Genzyme Corporation | $883.86 | 2019-2025 | |
| Janssen Biotech, INC. | $759.23 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Sun Pharmaceutical Industries INC. | $627.95 | 2019-2023 | Winlevi, Absorica Ld |
| Regeneron Healthcare Solutions, INC. | $400.50 | 2019-2025 | Dupixent |
| Almirall LLC | $391.53 | 2019-2025 | Klisyri, Seysara |
| Pfizer INC. | $343.60 | 2019-2025 | |
| Lilly USA, LLC | $285.96 | 2019-2024 | Taltz, Olumiant |
| Amgen INC. | $262.67 | 2019-2025 | Otezla, Otezla |
| Incyte Corporation | $261.20 | 2023-2025 | Opzelura |
| Mayne Pharma Commercial LLC | $179.78 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $173.22 | 2022-2024 | Sotyktu |
| Strata Skin Sciences, INC. | $141.93 | 2025 | Xtrac |
| Vyne Pharmaceuticals INC. | $126.76 | 2020 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alice Wuu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.